Literature DB >> 24782454

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

R Stupp1, M Brada2, M J van den Bent3, J-C Tonn4, G Pentheroudakis5.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24782454     DOI： 10.1093/annonc/mdu050

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  201 in total

Review 1.  Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.

Authors:  Maria Protopapa; Anna Zygogianni; Georgios S Stamatakos; Christos Antypas; Christina Armpilia; Nikolaos K Uzunoglu; Vassilis Kouloulias
Journal:  J Neurooncol       Date:  2017-10-28       Impact factor: 4.130

2.  A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.

Authors:  Alba A Brandes; Antoine F Carpentier; Santosh Kesari; Juan M Sepulveda-Sanchez; Helen R Wheeler; Olivier Chinot; Lawrence Cher; Joachim P Steinbach; David Capper; Pol Specenier; Jordi Rodon; Ann Cleverly; Claire Smith; Ivelina Gueorguieva; Colin Miles; Susan C Guba; Durisala Desaiah; Michael M Lahn; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2016-02-21       Impact factor: 12.300

3.  Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).

Authors:  Mary Lou Affronti; Sarah Woodring; Karen Allen; John Kirkpatrick; Katherine B Peters; James E Herndon; Frances McSherry; Patrick N Healy; Annick Desjardins; James J Vredenburgh; Henry S Friedman
Journal:  Support Care Cancer       Date:  2016-06-06       Impact factor: 3.603

4.  Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

Authors:  Sheng Han; Xiang Li; Bo Qiu; Tao Jiang; Anhua Wu
Journal:  J Neurooncol       Date:  2015-05-26       Impact factor: 4.130

5.  Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Authors:  Joshua D Palmer; Joshua Siglin; Kosj Yamoah; Tu Dan; Colin E Champ; Voichita Bar-Ad; Maria Werner-Wasik; James J Evans; Lyndon Kim; Jon Glass; Christopher Farrell; David W Andrews; Wenyin Shi
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

6.  Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model.

Authors:  Martin Connock; Peter Auguste; Claude Dussart; Jacques Guyotat; Xavier Armoiry
Journal:  J Neurooncol       Date:  2019-05-24       Impact factor: 4.130

Review 7.  The role of radiation in treating glioblastoma: here to stay.

Authors:  Christopher D Corso; Ranjit S Bindra; Minesh P Mehta
Journal:  J Neurooncol       Date:  2017-03-07       Impact factor: 4.130

8.  Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?

Authors:  Marc Zanello; Alexandre Roux; Renata Ursu; Sophie Peeters; Luc Bauchet; Georges Noel; Jacques Guyotat; Pierre-Jean Le Reste; Thierry Faillot; Fabien Litre; Nicolas Desse; Evelyne Emery; Antoine Petit; Johann Peltier; Jimmy Voirin; François Caire; Jean-Luc Barat; Jean-Rodolphe Vignes; Philippe Menei; Olivier Langlois; Edouard Dezamis; Antoine Carpentier; Phong Dam Hieu; Philippe Metellus; Johan Pallud
Journal:  J Neurooncol       Date:  2017-07-19       Impact factor: 4.130

9.  Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival.

Authors:  Rikke H Dahlrot; Pia Larsen; Henning B Boldt; Melissa S Kreutzfeldt; Steinbjørn Hansen; Jacob B Hjelmborg; Bjarne Winther Kristensen
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

10.  Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Yoshihiko Fukukura; Hirofumi Hirano; Yuko Goto; Masashi Sasaki; Yuta Akamine; Jochen Keupp; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.